NUVB Nuvation Bio Inc.

Fundamentals / CIK 0001811063 / USD

Nuvation Bio Inc. reported $201.7M in revenue and a net loss of $135.9M for the trailing twelve months ended September 30, 2026 (up 242.6% year over year), with a -61.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NUVB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$122.0M$60.99M$0-$536.4MFY 2020 Net Income: -$41.66M2020FY 2021 Net Income: -$86.85M2021FY 2022 Net Income: -$104.2M2022FY 2023 Revenue: $0FY 2023 Net Income: -$75.80M2023FY 2024 Revenue: $7.87MFY 2024 Net Income: -$567.9M2024FY 2025 Revenue: $62.90MFY 2025 Net Income: -$204.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $62.90M $7.87M $0 -- -- --
Cost of Revenue -- $7.08M $0 -- -- --
Gross Profit -- $795K $0 -- -- --
Research & Development $115.1M $99.12M $71.29M $87.81M $69.04M $32.60M
Selling, General & Admin $151.6M $69.23M $28.53M -- -- --
Total Operating Expenses $276.0M $600.5M $99.82M $119.7M $93.32M $43.55M
Operating Income -$213.1M -$592.6M -$99.82M -$119.7M -$93.32M -$43.55M
EBITDA -$211.3M -$591.9M -$99.60M -$119.5M -$93.13M -$43.45M
Interest Income $21.43M $27.06M $24.61M $7.45M $2.96M $1.95M
Interest Expense $13.68M $341K $0 -- -- --
Income Before Tax -$204.6M -$567.9M -$75.80M -$104.2M -$86.85M -$41.66M
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$204.6M -$567.9M -$75.80M -$104.2M -$86.85M -$41.66M
Basic EPS -$0.60 -$2.11 -$0.35 -$0.48 -$0.44 -$0.43
Diluted EPS -$0.60 -$2.11 -$0.35 -$0.48 -$0.44 -$0.43
Basic Shares Outstanding 341.5K 268.8K 218.9K 216.7K 197.9K 97.5M
Diluted Shares Outstanding 341.5K 268.8K 218.9K 216.7K 197.9K 97.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $44.95M $31.69M $83.23M $41.87M $13.12M $4.83M $3.08M $5.71M
Cost of Revenue -- -- -- -- $3.35M $2.58M $2.09M $4.22M
Gross Profit -- -- -- -- $9.77M $2.26M $990K $1.50M
Research & Development $32.68M $30.66M $35.05M $34.30M $28.85M $27.36M $24.60M $29.30M
Selling, General & Admin $42.55M $42.59M $38.31M $40.33M $37.36M $38.48M $35.39M $26.14M
Total Operating Expenses $87.16M $82.72M $79.35M $75.90M $69.55M $68.42M $62.09M $62.52M
Operating Income -$42.21M -$51.04M $3.88M -$34.04M -$56.43M -$63.59M -$59.00M -$53.94M
EBITDA -$41.63M -$50.50M $4.42M -$33.50M -$55.90M -$63.23M -$58.69M -$53.72M
Interest Income $6.16M $4.60M $5.11M $5.30M $6.03M $4.78M $5.32M $6.06M
Interest Expense $881K $6.76M $6.71M $6.67M $5.12M $421K $54K $89K
Income Before Tax -$41.90M -$62.84M $5.40M -$36.59M -$55.79M -$59.01M -$53.24M -$49.45M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$41.90M -$62.84M $5.40M -$36.59M -$55.79M -$59.01M -$53.24M -$49.45M
Basic EPS -$0.12 -$0.18 $0.02 -- -$0.16 -$0.17 -$0.16 --
Diluted EPS -$0.12 -$0.18 $0.01 -- -$0.16 -$0.17 -$0.16 --
Basic Shares Outstanding 351.9K 348.8K 347.3K -- 342.4K 340.7K 338.6K --
Diluted Shares Outstanding 351.9K 348.8K 377.5K -- 342.4K 340.7K 338.6K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $164.1M $35.72M $42.65M $101.1M $132.4M $29.75M
Short-Term Investments $365.1M $467.0M $568.6M $559.9M $633.0M $186.0M
Cash & Short-Term Investments $529.2M $502.7M $611.2M $661.0M $765.4M $215.8M
Accounts Receivable, Net $16.08M $12.72M $0 -- -- --
Inventory $11.41M $0 -- -- -- --
Total Current Assets $571.5M $526.3M $616.4M $667.3M $772.1M $220.7M
Property, Plant & Equipment, Net $564K $586K $717K $894K $786K $688K
Intangible Assets $11.21M $4.62M $0 -- -- --
Other Non-Current Assets $7.61M $6.76M $587K $0 -- --
Total Non-Current Assets $23.30M $14.37M $5.05M $4.82M $4.08M $1.11M
Total Assets $594.8M $540.6M $621.5M $672.1M $776.2M $221.8M
Accounts Payable $9.48M $6.35M $2.21M $2.14M $3.92M $2.17M
Short-Term Debt $5.72M $6.28M $0 -- -- --
Deferred Revenue (Current) $7.51M $11.12M $0 -- -- --
Total Current Liabilities $82.23M $58.24M $13.97M $13.16M $16.93M $6.55M
Deferred Revenue (Non-Current) $145.8M $15.57M $0 -- -- --
Total Non-Current Liabilities $206.9M $18.59M $2.39M $3.90M $13.23M $157K
Total Liabilities $289.1M $76.84M $16.36M $17.07M $30.15M $6.71M
Total Debt (incl. Leases) $10.15M $8.91M $4.01M $4.26M $3.06M --
Common Stock $1.42B $1.37B $947.7M $927.6M $910.0M $289.5M
Retained Earnings -$1.12B -$910.7M -$342.8M -$267.0M -$162.8M -$75.95M
Accumulated Other Comp. Income -$187K $573K $181K -$5.53M -$1.19M $1.56M
Total Stockholders' Equity $305.7M $463.8M $605.1M $655.1M $746.0M $215.1M
Total Equity $305.7M $463.8M $605.1M $655.1M $746.0M $215.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $153.8M $258.6M $125.4M $164.1M $98.90M $248.0M $47.98M $35.72M
Short-Term Investments $509.6M $402.4M $408.3M $365.1M $450.1M $359.8M $413.7M $467.0M
Cash & Short-Term Investments $663.4M $661.0M $533.7M $529.2M $549.0M $607.7M $461.7M $502.7M
Accounts Receivable, Net $36.55M $27.83M $22.72M $16.08M $8.32M $2.69M $409K $12.72M
Inventory $15.34M $19.90M $15.84M $11.41M $5.71M $552K $14K $0
Total Current Assets $734.7M $726.4M $591.5M $571.5M $577.5M $623.2M $475.6M $526.3M
Property, Plant & Equipment, Net $2.22M $715K $535K $564K $560K $615K $562K $586K
Intangible Assets $19.80M $10.29M $10.76M $11.21M $11.68M $12.14M $4.41M $4.62M
Other Non-Current Assets $7.52M $3.82M $3.82M $7.61M $7.46M $6.62M $6.62M $6.76M
Total Non-Current Assets $43.73M $18.07M $18.71M $23.30M $24.03M $24.02M $16.92M $14.37M
Total Assets $778.4M $744.5M $610.2M $594.8M $601.6M $647.2M $492.5M $540.6M
Accounts Payable $9.45M $12.09M $22.43M $9.48M $15.36M $22.42M $10.54M $6.35M
Short-Term Debt $5.97M $5.89M $5.79M $5.72M $5.62M $5.58M $5.68M $6.28M
Deferred Revenue (Current) $9.06M $8.86M $8.65M $7.51M $6.72M $9.72M $10.77M $11.12M
Total Current Liabilities $98.56M $86.75M $79.52M $82.23M $68.13M $66.36M $52.77M $58.24M
Deferred Revenue (Non-Current) $151.5M $151.1M $151.9M $145.8M $144.6M $142.8M $13.61M $15.57M
Total Non-Current Liabilities $451.9M $403.9M $211.2M $206.9M $207.5M $208.0M $20.26M $18.59M
Total Liabilities $550.4M $490.6M $290.7M $289.1M $275.7M $274.3M $73.03M $76.84M
Total Debt (incl. Leases) $20.63M $9.52M $9.83M $10.15M $10.46M $10.79M $11.41M $8.91M
Common Stock $1.45B $1.43B $1.43B $1.42B $1.40B $1.40B $1.38B $1.37B
Retained Earnings -$1.21B -$1.17B -$1.11B -$1.12B -$1.08B -$1.02B -$964.0M -$910.7M
Accumulated Other Comp. Income -$4.62M -$2.61M -$1.68M -$187K -$139K -$327K $545K $573K
Total Stockholders' Equity $228.0M $253.9M $319.6M $305.7M $325.9M $372.9M $419.5M $463.8M
Total Equity $228.0M $253.9M $319.6M $305.7M $325.9M $372.9M $419.5M $463.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$204.6M -$567.9M -$75.80M -$104.2M -$86.85M -$41.66M
Depreciation & Amortization $1.74M $683K $222K $199K $184K $103K
Stock-Based Compensation $35.89M $32.27M $19.51M $16.29M $9.27M $2.20M
Change in Receivables -$3.35M -$12.72M $0 -- -- --
Change in Payables $3.13M -$1.65M $70K -$1.79M $1.86M $34K
Operating Cash Flow -$173.4M -$130.4M -$68.00M -$96.11M -$68.19M -$36.53M
Purchases of Investments -$354.4M -$339.6M -$703.4M -$520.3M -$609.3M -$143.3M
Investing Cash Flow $99.52M $122.7M $8.92M $63.46M -$454.7M -$70.32M
Financing Cash Flow $202.5M $331K $628K $1.33M $625.5M $133.1M
Net Change in Cash $128.4M -$6.93M -$58.45M -$31.32M $102.7M $26.29M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$41.90M -$62.84M $5.40M -$36.59M -$55.79M -$59.01M -$53.24M -$49.45M
Depreciation & Amortization $578K $536K $536K $539K $534K $356K $310K $219K
Stock-Based Compensation $10.07M $10.46M $9.03M $7.99M $8.02M $12.03M $7.85M $10.19M
Change in Receivables -$8.72M -$5.10M -$6.65M -$7.75M -$5.63M -$2.28M $12.31M -$12.61M
Change in Payables -$2.64M -$9.85M $12.96M -$5.88M -$7.06M $11.88M $4.19M -$6.03M
Operating Cash Flow -$38.56M -$42.97M $5.07M -$29.73M -$52.89M -$48.18M -$42.63M -$46.30M
Purchases of Investments -$225.9M -$67.69M -$82.15M -$44.90M -$167.1M -$81.67M -$60.71M -$32.04M
Investing Cash Flow -$109.3M $5.99M -$43.64M $87.08M -$96.62M $54.88M $54.18M $51.77M
Financing Cash Flow $43.16M $170.5M $44K $8.06M $501K $193.4M $548K -$900K
Net Change in Cash -$104.8M $133.2M -$38.70M $65.19M -$149.1M $200.0M $12.25M $5.69M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- 10.1% -- -- -- --
Operating Margin -338.7% -7527.3% -- -- -- --
Net Profit Margin -325.3% -7213.8% -- -- -- --
Return on Equity (ROE) -66.9% -122.5% -12.5% -15.9% -11.6% -19.4%
Return on Assets (ROA) -34.4% -105.1% -12.2% -15.5% -11.2% -18.8%
Current Ratio 6.95x 9.04x 44.11x 50.70x 45.62x 33.69x
Quick Ratio 6.81x 9.04x 43.74x 50.23x 45.22x 32.93x
Debt to Equity 0.03x 0.02x 0.01x 0.01x 0.00x --
Revenue Growth (YoY) +699.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- -- 54.3% 27.5% 16.3% 10.1%
Operating Margin -61.2% -81.0% -105.0% -338.7% -871.0% -1564.9% -5762.8% -7527.3%
Net Profit Margin -67.4% -88.2% -102.1% -325.3% -813.1% -1413.4% -5534.2% -7213.8%
Return on Equity (ROE) -59.6% -59.0% -45.7% -66.9% -66.7% -54.4% -144.6% -122.5%
Return on Assets (ROA) -17.5% -20.1% -23.9% -34.4% -36.2% -31.3% -123.1% -105.1%
Current Ratio 7.45x 8.37x 7.44x 6.95x 8.48x 9.39x 9.01x 9.04x
Quick Ratio 7.30x 8.14x 7.24x 6.81x 8.39x 9.38x 9.01x 9.04x
Debt to Equity 0.09x 0.04x 0.03x 0.03x 0.03x 0.03x 0.03x 0.02x
Revenue Growth (YoY) +242.6% +555.6% +2598.7% +633.1% +1704.7% +236.8% -- --
Gross Profit Growth (YoY) -- -- -- -- -- +2464.8% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001811063) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:26 UTC · Open in terminal